These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28564596)

  • 21. Histone variant macroH2A1.2 is mono-ubiquitinated at its histone domain.
    Ogawa Y; Ono T; Wakata Y; Okawa K; Tagami H; Shibahara KI
    Biochem Biophys Res Commun; 2005 Oct; 336(1):204-9. PubMed ID: 16129414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase.
    Sato K; Hayami R; Wu W; Nishikawa T; Nishikawa H; Okuda Y; Ogata H; Fukuda M; Ohta T
    J Biol Chem; 2004 Jul; 279(30):30919-22. PubMed ID: 15184379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis.
    Salas-Lloret D; García-Rodríguez N; Soto-Hidalgo E; González-Vinceiro L; Espejo-Serrano C; Giebel L; Mateos-Martín ML; de Ru AH; van Veelen PA; Huertas P; Vertegaal ACO; González-Prieto R
    Nat Commun; 2024 May; 15(1):4292. PubMed ID: 38769345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ubiquitination and proteasome-mediated degradation of BRCA1 and BARD1 during steroidogenesis in human ovarian granulosa cells.
    Lu Y; Amleh A; Sun J; Jin X; McCullough SD; Baer R; Ren D; Li R; Hu Y
    Mol Endocrinol; 2007 Mar; 21(3):651-63. PubMed ID: 17185394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.
    Xia Y; Pao GM; Chen HW; Verma IM; Hunter T
    J Biol Chem; 2003 Feb; 278(7):5255-63. PubMed ID: 12431996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.
    Baer R; Ludwig T
    Curr Opin Genet Dev; 2002 Feb; 12(1):86-91. PubMed ID: 11790560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.
    Morris JR; Solomon E
    Hum Mol Genet; 2004 Apr; 13(8):807-17. PubMed ID: 14976165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
    Hashizume R; Fukuda M; Maeda I; Nishikawa H; Oyake D; Yabuki Y; Ogata H; Ohta T
    J Biol Chem; 2001 May; 276(18):14537-40. PubMed ID: 11278247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function.
    Sankaran S; Starita LM; Simons AM; Parvin JD
    Cancer Res; 2006 Apr; 66(8):4100-7. PubMed ID: 16618730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.
    Wu-Baer F; Ludwig T; Baer R
    Mol Cell Biol; 2010 Jun; 30(11):2787-98. PubMed ID: 20351172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA1/BARD1 ubiquitinate phosphorylated RNA polymerase II.
    Starita LM; Horwitz AA; Keogh MC; Ishioka C; Parvin JD; Chiba N
    J Biol Chem; 2005 Jul; 280(26):24498-505. PubMed ID: 15886201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone tail electrostatics modulate E2-E3 enzyme dynamics: a gateway to regulate ubiquitination machinery.
    Ranathunga DTS; Torabifard H
    Phys Chem Chem Phys; 2023 Jan; 25(4):3361-3374. PubMed ID: 36633205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin.
    Wu-Baer F; Lagrazon K; Yuan W; Baer R
    J Biol Chem; 2003 Sep; 278(37):34743-6. PubMed ID: 12890688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
    Hayami R; Sato K; Wu W; Nishikawa T; Hiroi J; Ohtani-Kaneko R; Fukuda M; Ohta T
    Cancer Res; 2005 Jan; 65(1):6-10. PubMed ID: 15665273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRL4-DCAF8L2 E3 ligase promotes ubiquitination and degradation of BARD1.
    Deng J; Zhang T; Liu F; Han Q; Li Q; Guo X; Ma Y; Li L; Shao G
    Biochem Biophys Res Commun; 2022 Jun; 611():107-113. PubMed ID: 35487060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic interactions of proteins in complex networks: identifying the complete set of interacting E2s for functional investigation of E3-dependent protein ubiquitination.
    Christensen DE; Klevit RE
    FEBS J; 2009 Oct; 276(19):5381-9. PubMed ID: 19712108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico investigation on the mutational analysis of BRCA1-BARD1 RING domains and its effect on nucleosome recognition and ubiquitination.
    Sarma H; Kiewhuo K; Jamir E; Sastry GN
    Biophys Chem; 2023 Sep; 300():107070. PubMed ID: 37339533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRCA1 DNA-binding activity is stimulated by BARD1.
    Simons AM; Horwitz AA; Starita LM; Griffin K; Williams RS; Glover JN; Parvin JD
    Cancer Res; 2006 Feb; 66(4):2012-8. PubMed ID: 16489000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRCA1/BARD1 intrinsically disordered regions facilitate chromatin recruitment and ubiquitylation.
    Witus SR; Tuttle LM; Li W; Zelter A; Wang M; Kermoade KE; Wilburn DB; Davis TN; Brzovic PS; Zhao W; Klevit RE
    EMBO J; 2023 Aug; 42(15):e113565. PubMed ID: 37305927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative proteomic identification of the BRCA1 ubiquitination substrates.
    Song M; Hakala K; Weintraub ST; Shiio Y
    J Proteome Res; 2011 Nov; 10(11):5191-8. PubMed ID: 21950761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.